Skip to main content
AstraZeneca Pharma India Ltd. logo

AstraZeneca Pharma India Ltd. — Investor Relations & Filings

Ticker · ASTRAZEN ISIN · INE203A01020 LEI · 335800N8M7W5JDTAHR68 BSE.NS Manufacturing
Open in API
Filings indexed 1,261 across all filing types
Latest filing 2024-04-12 Regulatory Filings
Country IN India
Listing BSE.NS ASTRAZEN

About AstraZeneca Pharma India Ltd.

https://www.astrazeneca.com/content/az-…

AstraZeneca Pharma India Ltd. is a science-led biopharmaceutical organization dedicated to the discovery, development, and commercialization of innovative prescription medicines. The company focuses on core therapeutic areas including Oncology, Cardiovascular, Renal & Metabolism, Respiratory & Immunology, and Rare Disease. Its product portfolio includes advanced treatments such as Tagrisso, Lynparza, and Imfinzi for various cancers, as well as Forxiga and Brilinta for metabolic and cardiovascular conditions. The company utilizes a robust global research pipeline to address complex medical challenges and improve patient outcomes. Through clinical research and specialized healthcare solutions, it delivers transformative therapies designed to treat chronic and life-threatening diseases. The organization is characterized by its commitment to scientific excellence and the delivery of high-value medical interventions.

Recent filings

Filing Released Lang Actions
This is to certify that Integrated Registry Management Services Private Limited, are the Company''s RTA and that all activities are in relation to the share transfer are maintained by them. We ....
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, certifying that the company's Registrar and Transfer Agents maintain all activities related to share transfers. It is addressed to stock exchanges and confirms compliance with regulatory requirements. The document is short (3365 characters) and primarily serves as a certification letter rather than a financial report or detailed filing. It does not contain financial statements, management discussion, or other report content. Therefore, it fits best under Regulatory Filings (RNS), which covers officer certifications, attestations, and miscellaneous regulatory announcements that do not fit other categories.
2024-04-12 English
We are enclosing herewith the Certificate dated April 5, 2024 issued by the RTA of the Company confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.
Regulatory Filings Classification · 95% confidence The document is a certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, issued by the Registrar and Transfer Agent confirming compliance with dematerialization and related securities regulations for the period 01.03.2024 to 31.03.2024. It is addressed to stock exchanges and signed by the company secretary. The document is short (3248 characters) and primarily serves as a compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or detailed financial data. It is a regulatory compliance filing related to securities and share dematerialization. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and certifications that do not fit other specific categories.
2024-04-12 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate issued pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming compliance related to dematerialization of securities for the period 01.03.2024 to 31.03.2024. It is addressed to stock exchanges and signed by the company secretary and the registrar and transfer agent. The document is short (3248 characters) and primarily serves as a compliance certificate rather than a full financial report or announcement of financial results. It does not contain financial statements or detailed financial data. It is a regulatory compliance filing related to securities dematerialization and transfer agent confirmation, which fits best under Regulatory Filings (RNS) as it does not match any other specific category such as Annual Report, Earnings Release, or Capital Update.
2024-04-12 English
This is in reference to our letter dated March 6, 2024, enclosing therewith a Postal Ballot Notice dated February 8, 2024 seeking consent of the members of the Company through Special Resolution ....
Regulatory Filings
2024-04-08 English
Shareholders meeting
Regulatory Filings
2024-04-08 English
In furtherance to your email dated April 6, 2024 and the enclosed summary of proceedings of 44th Annual General Meeting held on August 14, 2023, we wish to inform that that the 44th Annual ....
AGM Information Classification · 95% confidence The document is a communication to stock exchanges (BSE and NSE) regarding the summary of proceedings of the 44th Annual General Meeting (AGM) held on August 14, 2023. It lists the business transacted at the AGM, including adoption of financial statements, dividend declaration, director appointment, related party transactions, and auditor remuneration ratification. It also mentions that voting results will be announced later upon receipt of the Scrutinizer's Report. The document is short (3214 characters) and serves as a summary or announcement of the AGM proceedings rather than the full AGM materials or minutes. This fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or summaries of the meeting proceedings. It is not a full Annual Report, nor a voting results declaration (which would be DVA), nor a regulatory filing or other category. Therefore, the best classification is AGM Information (AGM-R).
2024-04-08 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.